61 results on '"Nissen, N. I."'
Search Results
2. Effect of methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's disease.
3. Lymphoblastic lymphoma: a clinicopathologic study of 95 patients.
4. Phase II trial of cis-dichlorodiammineplatinum (II) in advanced malignant lymphoma: a study of the cancer and acute leukemia group B.
5. The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study.
6. Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group B.
7. Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan).
8. Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma.
9. Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group B.
10. Tumor cell concentration and tumor burden in relation to histopathologic subtype and other prognostic factors in early stage Hodgkin's disease. The Danish National Hodgkin Study Group.
11. A simplified working formulation of non-Hodgkin's lymphomas based on quantifiable histologic criteria.
12. Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment.
13. Comparison of the working formulation of non-Hodgkin's lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution.
14. Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients.
15. Effects of interleukin-3 following chemotherapy of non-Hodgkin's lymphoma. A prospective, controlled phase I/II study.
16. In vivo kinetics of 111Indium-labelled autologous granulocytes following i.v. administration of granulocyte-macrophage colony-stimulating factor (GM-CSF).
17. High-risk AML evidenced by a monoclonal antibody.
18. Hodgkin's disease stages I and II with infradiaphragmatic presentation: A rare and prognostically unfavourable combination.
19. Cefotaxime versus Ampicillin, Methicillin and Netilmicin in Combination for Treatment of Febrile Episodes in Patients with Haematologic Malignancy.
20. Clinical Trial of Prednimustine, Leo-1031 (NSC-134087), in Patients with Non-Hodgkin Lymphomata and Chronic Lymphocytic Leukaemia Previously Treated with Steroids and Alkylating Agents.
21. Clinical pharmacokinetic studies of a human haemopoietic growth factor, GM-CSF.
22. Modulation of neutrophil and monocyte function by recombinant human granulocyte macrophage colony-stimulating factor in patients with lymphoma.
23. Pharmacokinetic and pharmacodynamic studies of subcutaneously administered recombinant human interleukin-3 following chemotherapy for non-Hodgkin's lymphoma.
24. Recombinant human interleukin-3: pharmacokinetics after intravenous and subcutaneous bolus injection and effects on granulocyte kinetics.
25. Abolished Production of Interferon by Leucocytcs of Patients with the Acquired Cytogcnetic Abnormalities 5q - or - 5 in Secondary and de-Novo Acute Non-lymphocytic Leukaemia.
26. Clinical Trial of a New Peroral Diuretic, 1-allyl-3-ethyl-6-amino-uracil, Mictine.1.
27. Development of Nephrotic Syndrome during Treatment with Mercurial Diuretics.
28. Erythromyelosis.
29. Sulfonamide Hematuria.
30. Sulfamethyltiodiazole: (»Lucosil».).
31. Sulfathiazol and sulfamethylthiazol in the treatment of pneumonia.
32. Sulfamethylthiazol therapy in pneumonia.
33. Serum treatment of pneumonia in Denmark.
34. Serotherapeutic Studies on Lobar Pneumonia, especially Treatment with Rabbit Antipneumococcus Serum1.
35. Comparative Features of Epidemic and Endemic Poliomyelitis in Denmark1.
36. Studies on Non-Paralytic Poliomyelitis.
37. TOXOPLASMOSIS ACQUISITA LYMPHONODOSA IN A 62-YEAR-OLD WOMAN.
38. Comparative Studies on Spironolactone (Aldactone) and Chlorthalidone (Hygroton) in the Treatment of Arterial Hypertension.
39. Comparative Studies on the Diuretic and Biochemical Effects of Prednisone and Spironolactone in Hepatic Cirrhosis.
40. Comparative Studies on the Diuretic Effect of Chlorothiazide and Spironolactone in Cardiac and Hepatogenic Oedema.
41. Effect of a Thyroxine Analogue (Triiodothyropropionic Acid) on the Calcium-phosphorus Metabolism.
42. The Effect of Phenacetin Without Acetic-4-chloranilide on the Erythrocyte Lifetime in Phenacetin Habitués.
43. Further Study of the Mechanism of Reduction of Erythrocyte Survival Time in Phenacetin Habitués and its Relation to 'Phenacetin Kidney Disorders'.
44. Effect of Triiodothyropropionic Acid (Triopron) on Hypercholesterolaemia.
45. The Mechanism of Reduction of Erythrocyte Lifetime in Phenacetin Habitués with Renal Impairment.
46. Erythrocyte Survival Time in Persons Abusing Phenacetin, with or without Renal Insufficiency.
47. Necrosis of the Renal Papillae and Prolonged Abuse of Phenacetin.
48. Shock in Acute Myocardial Infarction and its Treatment with 1-Noradrenaline.
49. Bacteriaemia. Some Experiences Regarding Blood Cultures in a Medical Unit.
50. Further Clinical Trials of Oral Diuretics of the Aminouracil Group (Mictine, Rolicton1) Compared with the Diuretic Effect of Theophylline.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.